Servier’s Emi-Le Earns FDA Breakthrough Status
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026 Hill’s Pet Nutrition and Bond Pet Foods have announced a...
NEW YORK, May 6, 2026 Kingdom, a biotechnology company focused on clinically validated pet wellness ingredients, announced the publication...
NEW YORK, October 20, 2025 Healthy Paws, a Chubb company and a leading provider of pet health insurance, has...
